Virus causing respiratory tract illness in susceptible mammals

US9803252B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9803252-B2
Application numberUS-201715453764-A
CountryUS
Kind codeB2
Filing dateMar 8, 2017
Priority dateJan 19, 2001
Publication dateOct 31, 2017
Grant dateOct 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to the field of virology. The invention provides an isolated essentially mammalian negative-sense single-stranded RNA virus (MPV) within the subfamily Pneumovirinae of the family Paramyxoviridae and identifiable as phylogenetically corresponding to the genus Metapneumovirus and components thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A kit for determining the presence of metapneumovirus (MPV) in a mammalian subject, the kit comprising: a DNA probe of at least 10 nucleotides that specifically hybridizes to a target polynucleotide, wherein the target polynucleotide comprises a sequence encoding a polypeptide that is at least 90% identical to SEQ ID NO: 14 or the complement of the sequence, and wherein the DNA probe does not specifically hybridize to a polynucleotide from avian pneumovirus (APV). 2. The kit of claim 1 , wherein the DNA probe comprises at least 25 nucleotides. 3. The kit of claim 1 , wherein the DNA probe comprises at least 40 nucleotides. 4. The kit of claim 1 , wherein the DNA probe further comprises detectable marker. 5. The kit of claim 1 , wherein the target polynucleotide comprises a nucleic acid encoding SEQ ID NO: 14.

Assignees

Inventors

Classifications

  • Immunostimulants · CPC title

  • for RNA viruses · CPC title

  • Drugs for disorders of the respiratory system · CPC title

  • Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV] · CPC title

  • from viruses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9803252B2 cover?
The invention relates to the field of virology. The invention provides an isolated essentially mammalian negative-sense single-stranded RNA virus (MPV) within the subfamily Pneumovirinae of the family Paramyxoviridae and identifiable as phylogenetically corresponding to the genus Metapneumovirus and components thereof.
Who is the assignee on this patent?
Univ Erasmus Med Ct Rotterdam
What technology area does this patent fall under?
Primary CPC classification C12Q1/701. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).